Skip to main content
. 2023 Apr 10;109(5):1382–1399. doi: 10.1097/JS9.0000000000000302

Table 2.

Effectiveness of PDSIs on invasive treatment choice, decision-making–related outcomes, PROs, and outcomes related to healthcare resource use

Overall effect Test of heterogeneity
Outcomes Number of trials (references) Sample size Effect estimate (95% CI) Z P I 2 (%) χ2 P Certainty of evidence
Invasive treatment choice
 Postintervention 425153,55,58,59,61,6469,7278,80,8285,87,8991,9598,100107 9938 RR=0.97 (0.90, 1.04) −0.83 0.41 64.5 115.35 <0.001 Very low
 Follow-up (1–85 months) 651,72,84,92,100,102 1429 RR=1.05 (0.85, 1.30) 0.46 0.65 82.2 28.15 <0.001 Very low
Decision-making–related
 Decisional conflict
  Postintervention 275052,54,56,57,60,61,64,7174,76,7880,83,84,86,98,99,101,103,104,107 5726 g=−0.29 (−0.41, −0.16) −4.41 <0.001** 79.7 128.27 <0.001 Very low
  Follow-up (1–6 months) 650,51,79,84,86,103 1100 g=−0.11 (−0.23, 0.01) −1.84 0.07 0.0 2.70 0.75 Low
 Subscale of Decisional Conflict Scale
  Informed subscale 1356,57,60,64,7173,78,80,84,101,106 3215 g=−0.38 (−0.61, −0.14) −3.11 <0.001** 88.9 107.84 <0.001 Very low
  Values clarity subscale 1256,57,60,64,7173,78,80,84,101 2973 g=−0.25 (−0.41, −0.08) −2.89 <0.001** 74.8 43.69 <0.001 Very low
  Support subscale 1256,57,60,64,7173,78,80,84,101 2903 g=−0.17 (−0.29, −0.04) −2.65 0.01* 50.7 22.30 0.02 Very low
  Uncertainty subscale 1356,57,60,64,7173,78,80,84,101,106 3218 g=−0.10 (−0.17, −0.02) −2.52 0.01* 5.6 12.71 0.39 Low
  Effective decision subscale 1356,57,60,64,7173,78,80,84,101,106 3212 g=−0.14 (−0.23, −0.04) −2.80 0.01* 28.6 16.80 0.16 Very low
 Satisfaction with decision-making
  Postintervention 1857,60,63,66,67,70,72,73,77,78,80,84,86,98,103105 3744 g=0.09 (−0.05, 0.22) 1.26 0.21 71.7 60.0 <0.001 Very low
  Follow-up (6 months) 484,86,103,104 649 g=0.16 (0.01, 0.32) 2.09 0.04* 0.0 1.55 0.67 Moderate
 Disease and treatment knowledge
  Postintervention 1550,52,60,73,74,7780,84,89,95,98,104,106 4118 g=0.32 (0.15, 0.49) 3.65 <0.001** 84.6 90.98 <0.001 Very low
  Follow-up (1–6 months) 450,52,79,84 586 g=0.10 (−0.06, 0.27) 1.27 0.20 0.0 0.32 0.96 Moderate
 Decisional regret
  Postsurgery (immediately–6 months) 851,70,72,74,76,84,86,104 1043 g=−0.20 (−0.53, 0.13) −1.21 0.23 83.6 42.68 <0.001 Very low
  Follow-up (4–6 months) 351,74,104 551 g=0.03 (−0.36, 0.42) 0.14 0.89 80.2 10.10 0.01 Low
 Decision quality
  Postintervention 362,66,83 745 g=0.53 (−0.02, 1.09) 1.88 0.06 90.5 20.95 <0.001 Very low
  Values-concordance 462,66,89,107 1712 RR=1.98 (1.15, 3.39) 2.48 0.01* 90.2 30.68 <0.001 Very low
 Preparedness for decision-making 550,62,72,77,98 953 g=0.22 (0.09, 0.34) 3.36 <0.001** 0.0 3.27 0.51 Low
 Shared decision-making 366,72,73 1527 g=0.22 (−0.31, 0.75) 0.80 0.42 88.7 17.76 <0.001 Very low
 Decision self-efficacy 352,73,105 1595 g=0.02 (−0.07, 0.12) 0.48 0.63 0.0 0.32 0.85 Moderate
 Outcome expectations 352,74,98 526 g=0.11 (−0.57, 0.80) 0.32 0.75 93.5 30.55 <0.001 Very low
PROs
 General HRQoL
  Postintervention 551,71,72,95,96 862 g=0.02 (−0.20, 0.25) 0.21 0.84 58.3 9.59 0.05 Very low
  Follow-up (3–9 months) 351,71,96 461 g=0.13 (−0.18, 0.44) 0.84 0.40 61.3 5.17 0.08 Low
 Physical health 270,71 285 g=0.15 (−0.08, 0.38) 1.30 0.20 0.0 0.05 0.82 Moderate
 Mental health
  Postintervention 271,74 363 g=0.14 (−0.34, 0.62) 0.59 0.57 80.3 5.08 0.02 Low
  Follow-up (postoperative–4 months) 271,74 363 g=0.07 (−0.13. 0.28) 0.69 0.49 0.0 0.04 0.84 High
 Condition-specific HRQoL 566,76,83,99,104 379 g=0.28 (−0.11, 0.67) 1.39 0.17 67.8 12.4 0.01 Very low
 Anxiety
  Postintervention 974,78,80,95,96,99,103,105,106 1640 g=−0.03 (−0.20, 0.13) −0.40 0.69 57.9 19.0 0.01 Very low
  Follow-up (4–9 months) 374,96,103 513 g=−0.05 (−0.25, 0.16) −0.44 0.66 27.5 2.76 0.25 Moderate
 Depression
  Postintervention 651,74,95,96,103,104 1191 g=0.04 (−0.10, 0.17) 0.51 0.61 24.7 6.64 0.25 Moderate
  Follow-up (4–9 months) 451,74,96,103 749 g=−0.02 (−0.19, 0.14) −0.27 0.78 24.0 3.95 0.27 High
 Perceived stress 351,79,95 729 g=−0.00 (−0.19, 0.19) −0.00 1.00 40.6 3.37 0.19 High
Healthcare resources use
 Consultation time (min) 466,83,99,104 362 MD=0.04 (−0.17, 0.24) 0.37 0.71 0.0 1.42 0.70 Moderate

g, Hedges’s g; HRQoL, health-related quality of life; I 2, percentage of variation across studies that is due to heterogeneity rather than chance; MD, mean difference; PDSI, patient decision support intervention; PRO, patient-reported outcomes; RR, risk ratio; Z, overall effect size (Z-statistics); χ2, Cochran’s Q test.

*

P<0.05.

**

P<0.001.